However, in previous studies, SPARC/SPP1/BGLAP was deemed independent functional molecule rather than marker of osteomimicry, and was investigated separately in different cancer types and no one had combined these molecules and explored their prognostic value in pan-cancer analyses. The gene discussed is SPARC; the disease is cancer.